Capula Management’s Bristol-Myers Squibb BMY Stock Holding History

Capula Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$249K	Sell	4,113 -10,682	-72%	-$623K	﹤0.01%	689
2025 Q4	$798K	Buy	14,795 +10,941	+284%	+$526K	﹤0.01%	319
2025 Q3	$174K	Sell	3,854 -828	-18%	-$38.7K	﹤0.01%	641
2025 Q2	$217K	Buy	4,682 +2,373	+103%	+$116K	﹤0.01%	357
2025 Q1	$141K	Buy	+2,309	New	+$135K	﹤0.01%	586
2024 Q4	–	Sell	-17,276	Closed	-$894K	–	403
2024 Q3	$894K	Buy	+17,276	New	+$810K	0.01%	155
2023 Q3	–	Sell	-70,603	Closed	-$4.52M	–	521
2023 Q2	$4.52M	Sell	70,603 -842	-1%	-$56.5K	0.11%	101
2023 Q1	$4.95M	Sell	71,445 -153,868	-68%	-$10.9M	0.06%	238
2022 Q4	$16.2M	Buy	+225,313	New	+$17M	0.22%	122
2022 Q3	–	Sell	-1,023	Closed	-$74.2K	–	602
2022 Q2	$79K	Buy	+1,023	New	+$77.9K	﹤0.01%	300
2021 Q4	–	Sell	-33,586	Closed	-$1.99M	–	260
2021 Q3	$1.99M	Buy	33,586 +16,322	+95%	+$1.07M	0.02%	404
2021 Q2	$1.15M	Buy	17,264 +13,846	+405%	+$903K	0.02%	360
2021 Q1	$216K	Sell	3,418 -6,785	-67%	-$422K	﹤0.01%	439
2020 Q4	$633K	Buy	+10,203	New	+$627K	0.03%	233
2020 Q3	–	Sell	-95,558	Closed	-$5.75M	–	157
2020 Q2	$5.62M	Sell	95,558 -25,566	-21%	-$1.53M	0.2%	115
2020 Q1	$6.75M	Buy	+121,124	New	+$7.4M	0.24%	122

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capula Management's BMY Position: Q1 2026 in Review

Capula Management reduced its Bristol-Myers Squibb (BMY) stake by 72% in Q1 2026, selling an estimated $623K and leaving 4,113 shares worth $249K. The position accounts for ﹤0.01% of the portfolio, ranked #689.

Capula Management first reported a position in BMY in Q1 2020 and has held it in 16 quarters since. The position peaked at $16.2M in Q4 2022. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Capula Management held 4,113 shares of Bristol-Myers Squibb worth $249K as of Q1 2026.
Capula Management sold 10,682 Bristol-Myers Squibb shares in Q1 2026, an estimated $623K.
Bristol-Myers Squibb made up ﹤0.01% of Capula Management's portfolio in Q1 2026, its #689 holding.
Capula Management first reported a position in Bristol-Myers Squibb in Q1 2020 and has held it in 16 quarters since.
Capula Management's Bristol-Myers Squibb position peaked at $16.2M in Q4 2022.
2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Capula Management's 13F filing for Q1 2026, filed 14 May 2026.